These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 6172580)
41. Formulation design of carbamazepine fast-release tablets prepared by melt granulation technique. Perissutti B; Rubessa F; Moneghini M; Voinovich D Int J Pharm; 2003 Apr; 256(1-2):53-63. PubMed ID: 12695011 [TBL] [Abstract][Full Text] [Related]
42. Solid dispersion adsorbate technique for improved dissolution and flow properties of lurasidone hydrochloride: characterization using 3 Mahajan A; Surti N; Koladiya P Drug Dev Ind Pharm; 2018 Mar; 44(3):463-471. PubMed ID: 29098883 [TBL] [Abstract][Full Text] [Related]
43. Preparation and physicochemical evaluation of a new tacrolimus tablet formulation for sublingual administration. Srinarong P; Pham BT; Holen M; van der Plas A; Schellekens RC; Hinrichs WL; Frijlink HW Drug Dev Ind Pharm; 2012 Apr; 38(4):490-500. PubMed ID: 21961909 [TBL] [Abstract][Full Text] [Related]
44. New binary solid dispersion of indomethacin with surfactant polymer: from physical characterization to in vitro dissolution enhancement. Sivert A; Bérard V; Andrès C J Pharm Sci; 2010 Mar; 99(3):1399-413. PubMed ID: 19827098 [TBL] [Abstract][Full Text] [Related]
45. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique. Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080 [TBL] [Abstract][Full Text] [Related]
46. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions. Ghebremeskel AN; Vemavarapu C; Lodaya M Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443 [TBL] [Abstract][Full Text] [Related]
47. Preparation, characterization, and dissolution studies of ibuprofen solid dispersions using polyethylene glycol (PEG), talc, and PEG-talc as dispersion carriers. Khan GM; Jiabi Z Drug Dev Ind Pharm; 1998 May; 24(5):455-62. PubMed ID: 9876608 [TBL] [Abstract][Full Text] [Related]
48. Preparation, characterization and in vitro evaluation of tablets containing microwave-assisted solid dispersions of apremilast. Madan JR; Pawar AR; Patil RB; Awasthi R; Dua K Polim Med; 2018; 48(1):17-24. PubMed ID: 30657654 [TBL] [Abstract][Full Text] [Related]
49. Solid dispersions of nimodipine and polyethylene glycol 2000: dissolution properties and physico-chemical characterisation. Urbanetz NA; Lippold BC Eur J Pharm Biopharm; 2005 Jan; 59(1):107-18. PubMed ID: 15567307 [TBL] [Abstract][Full Text] [Related]
50. Preparation and properties of solid dispersion system containing citric acid and primidone. Summers MP; Enever RP J Pharm Sci; 1976 Nov; 65(11):1613-7. PubMed ID: 993992 [TBL] [Abstract][Full Text] [Related]
51. The compression of granulates containing solid dispersions. Kinget R; Kemel R Pharmazie; 1985 Jul; 40(7):475-7. PubMed ID: 4048252 [TBL] [Abstract][Full Text] [Related]
52. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach. Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898 [TBL] [Abstract][Full Text] [Related]
53. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures. Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867 [TBL] [Abstract][Full Text] [Related]
54. Dissolution rates of hydrocortisone and prednisone utilizing sugar solid dispersion systems in tablet form. Allen LV; Levinson RS; Martono DD J Pharm Sci; 1978 Jul; 67(7):979-81. PubMed ID: 660521 [TBL] [Abstract][Full Text] [Related]
55. Preparation of amorphous solid dispersions by rotary evaporation and KinetiSol Dispersing: approaches to enhance solubility of a poorly water-soluble gum extract. Bennett RC; Brough C; Miller DA; O'Donnell KP; Keen JM; Hughey JR; Williams RO; McGinity JW Drug Dev Ind Pharm; 2015 Mar; 41(3):382-97. PubMed ID: 24329130 [TBL] [Abstract][Full Text] [Related]
56. Physicochemical characterization of gliclazide-macrogol solid dispersion and tablets based on optimized dispersion. Khattab IS; Nada A; Zaghloul AA Drug Dev Ind Pharm; 2010 Aug; 36(8):893-902. PubMed ID: 20196643 [TBL] [Abstract][Full Text] [Related]
57. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder. Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911 [TBL] [Abstract][Full Text] [Related]
58. Roles of MgO release from polyethylene glycol 6000-based solid dispersions on microenvironmental pH, enhanced dissolution and reduced gastrointestinal damage of telmisartan. Tran PH; Tran TT; Lee SA; Nho VH; Chi SC; Lee BJ Arch Pharm Res; 2011 May; 34(5):747-55. PubMed ID: 21656360 [TBL] [Abstract][Full Text] [Related]
59. Preparation of lapatinib ditosylate solid dispersions using solvent rotary evaporation and hot melt extrusion for solubility and dissolution enhancement. Hu XY; Lou H; Hageman MJ Int J Pharm; 2018 Dec; 552(1-2):154-163. PubMed ID: 30268849 [TBL] [Abstract][Full Text] [Related]